Disease | cholangiocarcinoma |
Comorbidity | C0235974|pancreatic cancer |
Sentences | 1 |
PubMedID- 24559784 | Given the superior performance characteristics of eus-fna and the higher incidence of pancreatic cancer compared with cholangiocarcinoma, eus-fna should be performed before ercp in all patients with suspected malignant biliary obstruction. |
Page: 1